{
    "2020-11-30": [
        [
            {
                "time": "",
                "original_text": "A股头条之上市公司（12.1）",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华东医药再添新军 糖尿病首款DPP-4药物落地",
                "features": {
                    "keywords": [
                        "华东医药",
                        "DPP-4",
                        "糖尿病",
                        "新药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药西格列汀药品获得批文 将进一步丰富糖尿病产品管线",
                "features": {
                    "keywords": [
                        "华东医药",
                        "西格列汀",
                        "糖尿病",
                        "产品管线"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中美华东获得西格列汀二甲双胍片药品注册证书",
                "features": {
                    "keywords": [
                        "中美华东",
                        "西格列汀",
                        "二甲双胍",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药(000963.SZ)：“西格列汀二甲双胍片(I)”获药品注册证书",
                "features": {
                    "keywords": [
                        "华东医药",
                        "西格列汀",
                        "二甲双胍",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "500强榜单公布，医药再创新高，但这些白马却下跌了！谁跌的最惨？",
                "features": {
                    "keywords": [
                        "500强",
                        "医药",
                        "白马股",
                        "下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "还在等抄底？炒A股的“低价审美”行不通了",
                "features": {
                    "keywords": [
                        "抄底",
                        "低价审美",
                        "A股"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}